Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983;15(Suppl 2):155S–159S. doi: 10.1111/j.1365-2125.1983.tb05860.x

The classification of depression

E S Paykel
PMCID: PMC1427897  PMID: 6824551

Full text

PDF
156S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hollister L. E., Overall J. E., Johnson M. H., Shelton J., Kimbell I., Jr, Brunse A. Amitryptiline alone and combined with perphenazine in newly admitted depressed patients. J Nerv Ment Dis. 1966 May;142(5):460–469. [PubMed] [Google Scholar]
  2. Hollister L. E., Overall J. E., Shelton J., Pennington V., Kimbell I., Johnson M. Drug therapy of depression. Amitriptyline, perphenazine, and their combination in different syndromes. Arch Gen Psychiatry. 1967 Oct;17(4):486–493. doi: 10.1001/archpsyc.1967.01730280102012. [DOI] [PubMed] [Google Scholar]
  3. Johnstone E. C., Owens D. G., Frith C. D., McPherson K., Dowie C., Riley G., Gold A. Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychol Med. 1980 May;10(2):321–328. doi: 10.1017/s0033291700044081. [DOI] [PubMed] [Google Scholar]
  4. Katz M. M., Robins E., Croughan J., Secunda S., Swann A. Behavioural measurement and drug response characteristics of unipolar and bipolar depression. Psychol Med. 1982 Feb;12(1):25–36. doi: 10.1017/s0033291700043257. [DOI] [PubMed] [Google Scholar]
  5. Marks I. M., Stern R. S., Mawson D., Cobb J., McDonald R. Clomipramine and exposure for obsessive-compulsive rituals: i. Br J Psychiatry. 1980 Jan;136:1–25. doi: 10.1192/bjp.136.1.1. [DOI] [PubMed] [Google Scholar]
  6. Overall J. E., Hollister L. E., Johnson M., Pennington V. Nosology of depression and differential response to drugs. JAMA. 1966 Mar 14;195(11):946–948. [PubMed] [Google Scholar]
  7. Overall J. E., Rhoades H. M. Refinement of phenomenological classification in clinical psychopharmacology research. Psychopharmacology (Berl) 1982;77(1):24–30. doi: 10.1007/BF00436095. [DOI] [PubMed] [Google Scholar]
  8. Paykel E. S. Classification of depressed patients: a cluster analysis derived grouping. Br J Psychiatry. 1971 Mar;118(544):275–288. doi: 10.1192/bjp.118.544.275. [DOI] [PubMed] [Google Scholar]
  9. Paykel E. S. Depressive typologies and response to amitriptyline. Br J Psychiatry. 1972 Feb;120(555):147–156. doi: 10.1192/bjp.120.555.147. [DOI] [PubMed] [Google Scholar]
  10. Paykel E. S., Henderson A. J. Application of cluster analysis in the classification of depression. A replication study. Neuropsychobiology. 1977;3(2-3):111–119. doi: 10.1159/000117595. [DOI] [PubMed] [Google Scholar]
  11. Paykel E. S., Parker R. R., Penrose R. J., Rassaby E. R. Depressive classification and prediction of response to phenelzine. Br J Psychiatry. 1979 Jun;134:572–581. doi: 10.1192/bjp.134.6.572. [DOI] [PubMed] [Google Scholar]
  12. Paykel E. S., Prusoff B., Klerman G. L. The endogenous-neurotic continuum in depression: rater independence and factor distributions. J Psychiatr Res. 1971 Jun;8(2):73–90. doi: 10.1016/0022-3956(71)90010-0. [DOI] [PubMed] [Google Scholar]
  13. Prusoff B. A., Paykel E. S. Typological prediction of response to amitriptyline: a replication study. Int Pharmacopsychiatry. 1977;12(3):153–159. doi: 10.1159/000468302. [DOI] [PubMed] [Google Scholar]
  14. Ravaris C. L., Robinson D. S., Ives J. O., Nies A., Bartlett D. Phenelzine and amitriptyline in the treatment of depression. A comparison of present and past studies. Arch Gen Psychiatry. 1980 Sep;37(9):1075–1080. doi: 10.1001/archpsyc.1980.01780220113013. [DOI] [PubMed] [Google Scholar]
  15. Rosenthal S. H., Gudeman J. E. The endogenous depressive pattern. An empirical investigation. Arch Gen Psychiatry. 1967 Feb;16(2):241–249. doi: 10.1001/archpsyc.1967.01730200109016. [DOI] [PubMed] [Google Scholar]
  16. Rosenthal S. H., Gudeman J. E. The self-pitying constellation in depression. Br J Psychiatry. 1967 May;113(498):485–489. doi: 10.1192/bjp.113.498.485. [DOI] [PubMed] [Google Scholar]
  17. Rowan P. R., Paykel E. S., Parker R. R. Phenelzine and amitriptyline: effects on symptoms of neurotic depression. Br J Psychiatry. 1982 May;140:475–483. doi: 10.1192/bjp.140.5.475. [DOI] [PubMed] [Google Scholar]
  18. Sheehan D. V., Ballenger J., Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry. 1980 Jan;37(1):51–59. doi: 10.1001/archpsyc.1980.01780140053006. [DOI] [PubMed] [Google Scholar]
  19. Tyrer P. Towards rational therapy with monoamine oxidase inhibitors. Br J Psychiatry. 1976 Apr;128:354–360. doi: 10.1192/bjp.128.4.354. [DOI] [PubMed] [Google Scholar]
  20. WEST E. D., DALLY P. J. Effects of iproniazid in depressive syndromes. Br Med J. 1959 Jun 13;1(5136):1491–1494. doi: 10.1136/bmj.1.5136.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zitrin C. M., Klein D. F., Woerner M. G. Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatry. 1980 Jan;37(1):63–72. doi: 10.1001/archpsyc.1980.01780140065007. [DOI] [PubMed] [Google Scholar]
  22. van Praag H. M., Uleman A. M., Spitz J. C. The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex. Psychiatr Neurol Neurochir. 1965 Sep-Oct;68(5):329–346. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES